APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mitogen Activated Protein Kinase 14

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mitogen Activated Protein Kinase 14 Market Analysis and Forecast 2026-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchMitogen Activated Protein Kinase 14 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Mitogen Activated Protein Kinase 14 Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Mitogen Activated Protein Kinase 14 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mitogen Activated Protein Kinase 14 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Mitogen Activated Protein Kinase 14 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mitogen Activated Protein Kinase 14 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mitogen Activated Protein Kinase 14 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mitogen Activated Protein Kinase 14 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mitogen Activated Protein Kinase 14 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mitogen Activated Protein Kinase 14 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mitogen Activated Protein Kinase 14 include Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca Plc, Zocere, Inc., Toray Industries, Synovo GmbH, Chroma Therapeutics Limited, Chiesi Farmaceutici SpA and Astellas Pharma Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mitogen Activated Protein Kinase 14, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mitogen Activated Protein Kinase 14, also provides the sales of main regions and countries. Of the upcoming market potential for Mitogen Activated Protein Kinase 14, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mitogen Activated Protein Kinase 14 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mitogen Activated Protein Kinase 14 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mitogen Activated Protein Kinase 14 sales, projected growth trends, production technology, application and end-user industry.

Mitogen Activated Protein Kinase 14 Segment by Company

Eli Lilly and Company

GlaxoSmithKline Plc

AstraZeneca Plc

Zocere, Inc.

Toray Industries

Synovo GmbH

Chroma Therapeutics Limited

Chiesi Farmaceutici SpA

Astellas Pharma Inc.

Array BioPharma Inc.

Mitogen Activated Protein Kinase 14 Segment by Type

Ralimetinib Mesylate

Neflamapimod

Losmapimod

CHF-6297

Others

Mitogen Activated Protein Kinase 14 Segment by Application

Gastric Cancer

Epithelial Ovarian Cancer

Chronic Inflammation

Ulcerative Colitis

Others

Mitogen Activated Protein Kinase 14 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mitogen Activated Protein Kinase 14 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mitogen Activated Protein Kinase 14 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mitogen Activated Protein Kinase 14.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mitogen Activated Protein Kinase 14 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mitogen Activated Protein Kinase 14 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mitogen Activated Protein Kinase 14 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mitogen Activated Protein Kinase 14 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ralimetinib Mesylate Major Manufacturers Table 3. Neflamapimod Major Manufacturers Table 4. Losmapimod Major Manufacturers Table 5. CHF-6297 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Mitogen Activated Protein Kinase 14 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Gastric Cancer Major Manufacturers Table 9. Epithelial Ovarian Cancer Major Manufacturers Table 10. Chronic Inflammation Major Manufacturers Table 11. Ulcerative Colitis Major Manufacturers Table 12. Others Major Manufacturers Table 13. Mitogen Activated Protein Kinase 14 Industry Trends Table 14. Mitogen Activated Protein Kinase 14 Industry Drivers Table 15. Mitogen Activated Protein Kinase 14 Industry Opportunities and Challenges Table 16. Mitogen Activated Protein Kinase 14 Industry Restraints Table 17. Global Mitogen Activated Protein Kinase 14 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mitogen Activated Protein Kinase 14 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Mitogen Activated Protein Kinase 14 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2021-2026) Table 21. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2027-2032) Table 22. Global Mitogen Activated Protein Kinase 14 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Mitogen Activated Protein Kinase 14 Sales by Region (2021-2026) & (K Units) Table 24. Global Mitogen Activated Protein Kinase 14 Sales by Region (2027-2032) & (K Units) Table 25. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2021-2026) Table 26. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2027-2032) Table 27. Global Mitogen Activated Protein Kinase 14 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Mitogen Activated Protein Kinase 14 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Mitogen Activated Protein Kinase 14 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Mitogen Activated Protein Kinase 14 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Mitogen Activated Protein Kinase 14 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Mitogen Activated Protein Kinase 14 Manufacturers, Product Type & Application Table 35. Global Mitogen Activated Protein Kinase 14 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Mitogen Activated Protein Kinase 14 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Mitogen Activated Protein Kinase 14 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2021-2026) Table 42. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2027-2032) Table 43. Global Mitogen Activated Protein Kinase 14 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 45. Global Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 46. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2021-2026) Table 47. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2027-2032) Table 48. Global Mitogen Activated Protein Kinase 14 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Mitogen Activated Protein Kinase 14 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Mitogen Activated Protein Kinase 14 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2021-2026) Table 54. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2027-2032) Table 55. Global Mitogen Activated Protein Kinase 14 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 57. Global Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 58. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2021-2026) Table 59. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2027-2032) Table 60. Global Mitogen Activated Protein Kinase 14 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Mitogen Activated Protein Kinase 14 Price by Application (2027-2032) & (US$/Unit) Table 62. Eli Lilly and Company Company Information Table 63. Eli Lilly and Company Business Overview Table 64. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product Portfolio Table 66. Eli Lilly and Company Recent Development Table 67. GlaxoSmithKline Plc Company Information Table 68. GlaxoSmithKline Plc Business Overview Table 69. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product Portfolio Table 71. GlaxoSmithKline Plc Recent Development Table 72. AstraZeneca Plc Company Information Table 73. AstraZeneca Plc Business Overview Table 74. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product Portfolio Table 76. AstraZeneca Plc Recent Development Table 77. Zocere, Inc. Company Information Table 78. Zocere, Inc. Business Overview Table 79. Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Zocere, Inc. Mitogen Activated Protein Kinase 14 Product Portfolio Table 81. Zocere, Inc. Recent Development Table 82. Toray Industries Company Information Table 83. Toray Industries Business Overview Table 84. Toray Industries Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Toray Industries Mitogen Activated Protein Kinase 14 Product Portfolio Table 86. Toray Industries Recent Development Table 87. Synovo GmbH Company Information Table 88. Synovo GmbH Business Overview Table 89. Synovo GmbH Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Synovo GmbH Mitogen Activated Protein Kinase 14 Product Portfolio Table 91. Synovo GmbH Recent Development Table 92. Chroma Therapeutics Limited Company Information Table 93. Chroma Therapeutics Limited Business Overview Table 94. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product Portfolio Table 96. Chroma Therapeutics Limited Recent Development Table 97. Chiesi Farmaceutici SpA Company Information Table 98. Chiesi Farmaceutici SpA Business Overview Table 99. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product Portfolio Table 101. Chiesi Farmaceutici SpA Recent Development Table 102. Astellas Pharma Inc. Company Information Table 103. Astellas Pharma Inc. Business Overview Table 104. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolio Table 106. Astellas Pharma Inc. Recent Development Table 107. Array BioPharma Inc. Company Information Table 108. Array BioPharma Inc. Business Overview Table 109. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolio Table 111. Array BioPharma Inc. Recent Development Table 112. North America Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 115. North America Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 116. North America Mitogen Activated Protein Kinase 14 Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Mitogen Activated Protein Kinase 14 Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 121. North America Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 122. North America Mitogen Activated Protein Kinase 14 Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Mitogen Activated Protein Kinase 14 Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Units) Table 129. North America Mitogen Activated Protein Kinase 14 Sales by Country (2027-2032) & (K Units) Table 130. North America Mitogen Activated Protein Kinase 14 Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Mitogen Activated Protein Kinase 14 Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 133. Canada Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 134. Europe Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 137. Europe Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 138. Europe Mitogen Activated Protein Kinase 14 Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Mitogen Activated Protein Kinase 14 Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 143. Europe Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 144. Europe Mitogen Activated Protein Kinase 14 Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Mitogen Activated Protein Kinase 14 Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Units) Table 151. Europe Mitogen Activated Protein Kinase 14 Sales by Country (2027-2032) & (K Units) Table 152. Europe Mitogen Activated Protein Kinase 14 Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Mitogen Activated Protein Kinase 14 Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 155. France Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 156. U.K. Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 157. Italy Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 159. China Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 160. China Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 161. China Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 162. China Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 163. China Mitogen Activated Protein Kinase 14 Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Mitogen Activated Protein Kinase 14 Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 166. China Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 167. China Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 168. China Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 169. China Mitogen Activated Protein Kinase 14 Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Mitogen Activated Protein Kinase 14 Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 174. Asia Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 175. Asia Mitogen Activated Protein Kinase 14 Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Mitogen Activated Protein Kinase 14 Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 180. Asia Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 181. Asia Mitogen Activated Protein Kinase 14 Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Mitogen Activated Protein Kinase 14 Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Units) Table 188. Asia Mitogen Activated Protein Kinase 14 Sales by Country (2027-2032) & (K Units) Table 189. Asia Mitogen Activated Protein Kinase 14 Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Mitogen Activated Protein Kinase 14 Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 192. South Korea Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 193. India Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 194. Australia Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Mitogen Activated Protein Kinase 14 Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Mitogen Activated Protein Kinase 14 Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Mitogen Activated Protein Kinase 14 Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Mitogen Activated Protein Kinase 14 Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Mitogen Activated Protein Kinase 14 Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Mitogen Activated Protein Kinase 14 Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Mitogen Activated Protein Kinase 14 Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Mitogen Activated Protein Kinase 14 Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Mitogen Activated Protein Kinase 14 Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 218. Argentina Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 219. Chile Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 220. Colombia Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 221. Peru Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 223. Israel Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 224. UAE Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 225. Turkey Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 226. Iran Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 227. Egypt Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Mitogen Activated Protein Kinase 14 Distributors List Table 231. Mitogen Activated Protein Kinase 14 Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Mitogen Activated Protein Kinase 14 Image Figure 2. Global Mitogen Activated Protein Kinase 14 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mitogen Activated Protein Kinase 14 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ralimetinib Mesylate Image Figure 5. Neflamapimod Image Figure 6. Losmapimod Image Figure 7. CHF-6297 Image Figure 8. Others Image Figure 9. Global Mitogen Activated Protein Kinase 14 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Mitogen Activated Protein Kinase 14 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Gastric Cancer Image Figure 12. Epithelial Ovarian Cancer Image Figure 13. Chronic Inflammation Image Figure 14. Ulcerative Colitis Image Figure 15. Others Image Figure 16. Global Mitogen Activated Protein Kinase 14 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Mitogen Activated Protein Kinase 14 Revenue (2021-2032) & (US$ Million) Figure 18. Global Mitogen Activated Protein Kinase 14 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2021-2032) Figure 21. Global Mitogen Activated Protein Kinase 14 Sales (2021-2032) & (K Units) Figure 22. Global Mitogen Activated Protein Kinase 14 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Mitogen Activated Protein Kinase 14 Sales YoY (2021-2032) & (K Units) Figure 25. Europe Mitogen Activated Protein Kinase 14 Sales YoY (2021-2032) & (K Units) Figure 26. China Mitogen Activated Protein Kinase 14 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Mitogen Activated Protein Kinase 14 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Mitogen Activated Protein Kinase 14 Sales YoY (2021-2032) & (K Units) Figure 29. Global Mitogen Activated Protein Kinase 14 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Mitogen Activated Protein Kinase 14 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Mitogen Activated Protein Kinase 14 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2021-2032) Figure 35. Global Mitogen Activated Protein Kinase 14 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2021-2032) Figure 38. Global Mitogen Activated Protein Kinase 14 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2021-2032) Figure 41. Global Mitogen Activated Protein Kinase 14 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2021-2032) Figure 44. North America Mitogen Activated Protein Kinase 14 Revenue Share by Type (2021-2032) Figure 45. North America Mitogen Activated Protein Kinase 14 Sales Share by Type (2021-2032) Figure 46. North America Mitogen Activated Protein Kinase 14 Revenue Share by Application (2021-2032) Figure 47. North America Mitogen Activated Protein Kinase 14 Sales Share by Application (2021-2032) Figure 48. North America Mitogen Activated Protein Kinase 14 Revenue Share by Country (2021-2032) Figure 49. North America Mitogen Activated Protein Kinase 14 Sales Share by Country (2021-2032) Figure 50. Europe Mitogen Activated Protein Kinase 14 Revenue Share by Type (2021-2032) Figure 51. Europe Mitogen Activated Protein Kinase 14 Sales Share by Type (2021-2032) Figure 52. Europe Mitogen Activated Protein Kinase 14 Revenue Share by Application (2021-2032) Figure 53. Europe Mitogen Activated Protein Kinase 14 Sales Share by Application (2021-2032) Figure 54. Europe Mitogen Activated Protein Kinase 14 Revenue Share by Country (2021-2032) Figure 55. Europe Mitogen Activated Protein Kinase 14 Sales Share by Country (2021-2032) Figure 56. China Mitogen Activated Protein Kinase 14 Revenue Share by Type (2021-2032) Figure 57. China Mitogen Activated Protein Kinase 14 Sales Share by Type (2021-2032) Figure 58. China Mitogen Activated Protein Kinase 14 Revenue Share by Application (2021-2032) Figure 59. China Mitogen Activated Protein Kinase 14 Sales Share by Application (2021-2032) Figure 60. Asia Mitogen Activated Protein Kinase 14 Revenue Share by Type (2021-2032) Figure 61. Asia Mitogen Activated Protein Kinase 14 Sales Share by Type (2021-2032) Figure 62. Asia Mitogen Activated Protein Kinase 14 Revenue Share by Application (2021-2032) Figure 63. Asia Mitogen Activated Protein Kinase 14 Sales Share by Application (2021-2032) Figure 64. Asia Mitogen Activated Protein Kinase 14 Revenue Share by Country (2021-2032) Figure 65. Asia Mitogen Activated Protein Kinase 14 Sales Share by Country (2021-2032) Figure 66. SAMEA Mitogen Activated Protein Kinase 14 Revenue Share by Type (2021-2032) Figure 67. SAMEA Mitogen Activated Protein Kinase 14 Sales Share by Type (2021-2032) Figure 68. SAMEA Mitogen Activated Protein Kinase 14 Revenue Share by Application (2021-2032) Figure 69. SAMEA Mitogen Activated Protein Kinase 14 Sales Share by Application (2021-2032) Figure 70. SAMEA Mitogen Activated Protein Kinase 14 Revenue Share by Country (2021-2032) Figure 71. SAMEA Mitogen Activated Protein Kinase 14 Sales Share by Country (2021-2032) Figure 72. Mitogen Activated Protein Kinase 14 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Mitogen Activated Protein Kinase 14 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Ralimetinib Mesylate
  • Neflamapimod
  • Losmapimod
  • CHF-6297
  • Others
Applications
  • Gastric Cancer
  • Epithelial Ovarian Cancer
  • Chronic Inflammation
  • Ulcerative Colitis
  • Others
Companies covered
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Zocere, Inc.
  • Toray Industries
  • Synovo GmbH
  • Chroma Therapeutics Limited
  • Chiesi Farmaceutici SpA
  • Astellas Pharma Inc.
  • Array BioPharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mitogen Activated Protein Kinase 14 Market by Type
  3. 1.2.1 Global Mitogen Activated Protein Kinase 14 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ralimetinib Mesylate
  5. 1.2.3 Neflamapimod
  6. 1.2.4 Losmapimod
  7. 1.2.5 CHF-6297
  8. 1.2.6 Others
  9. 1.3 Mitogen Activated Protein Kinase 14 Market by Application
  10. 1.3.1 Global Mitogen Activated Protein Kinase 14 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Gastric Cancer
  12. 1.3.3 Epithelial Ovarian Cancer
  13. 1.3.4 Chronic Inflammation
  14. 1.3.5 Ulcerative Colitis
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Mitogen Activated Protein Kinase 14 Market Dynamics
  1. 2.1 Mitogen Activated Protein Kinase 14 Industry Trends
  2. 2.2 Mitogen Activated Protein Kinase 14 Industry Drivers
  3. 2.3 Mitogen Activated Protein Kinase 14 Industry Opportunities and Challenges
  4. 2.4 Mitogen Activated Protein Kinase 14 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mitogen Activated Protein Kinase 14 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mitogen Activated Protein Kinase 14 Revenue by Region
  3. 3.2.1 Global Mitogen Activated Protein Kinase 14 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mitogen Activated Protein Kinase 14 Revenue by Region (2021-2026)
  5. 3.2.3 Global Mitogen Activated Protein Kinase 14 Revenue by Region (2027-2032)
  6. 3.2.4 Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mitogen Activated Protein Kinase 14 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mitogen Activated Protein Kinase 14 Sales by Region
  9. 3.4.1 Global Mitogen Activated Protein Kinase 14 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mitogen Activated Protein Kinase 14 Sales by Region (2021-2026)
  11. 3.4.3 Global Mitogen Activated Protein Kinase 14 Sales by Region (2027-2032)
  12. 3.4.4 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mitogen Activated Protein Kinase 14 Revenue by Manufacturers
  2. 4.1.1 Global Mitogen Activated Protein Kinase 14 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mitogen Activated Protein Kinase 14 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mitogen Activated Protein Kinase 14 Sales by Manufacturers
  6. 4.2.1 Global Mitogen Activated Protein Kinase 14 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mitogen Activated Protein Kinase 14 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mitogen Activated Protein Kinase 14 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mitogen Activated Protein Kinase 14 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mitogen Activated Protein Kinase 14 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mitogen Activated Protein Kinase 14 Manufacturers, Product Type & Application
  13. 4.7 Global Mitogen Activated Protein Kinase 14 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mitogen Activated Protein Kinase 14 Market CR5 and HHI
  16. 4.8.2 2025 Mitogen Activated Protein Kinase 14 Tier 1, Tier 2, and Tier 3
5 Mitogen Activated Protein Kinase 14 Market by Type
  1. 5.1 Global Mitogen Activated Protein Kinase 14 Revenue by Type
  2. 5.1.1 Global Mitogen Activated Protein Kinase 14 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mitogen Activated Protein Kinase 14 Sales by Type
  6. 5.2.1 Global Mitogen Activated Protein Kinase 14 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mitogen Activated Protein Kinase 14 Price by Type
6 Mitogen Activated Protein Kinase 14 Market by Application
  1. 6.1 Global Mitogen Activated Protein Kinase 14 Revenue by Application
  2. 6.1.1 Global Mitogen Activated Protein Kinase 14 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mitogen Activated Protein Kinase 14 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mitogen Activated Protein Kinase 14 Sales by Application
  6. 6.2.1 Global Mitogen Activated Protein Kinase 14 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Mitogen Activated Protein Kinase 14 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mitogen Activated Protein Kinase 14 Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly and Company
  2. 7.1.1 Eli Lilly and Company Company Information
  3. 7.1.2 Eli Lilly and Company Business Overview
  4. 7.1.3 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly and Company Mitogen Activated Protein Kinase 14 Product Portfolio
  6. 7.1.5 Eli Lilly and Company Recent Developments
  7. 7.2 GlaxoSmithKline Plc
  8. 7.2.1 GlaxoSmithKline Plc Company Information
  9. 7.2.2 GlaxoSmithKline Plc Business Overview
  10. 7.2.3 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Plc Mitogen Activated Protein Kinase 14 Product Portfolio
  12. 7.2.5 GlaxoSmithKline Plc Recent Developments
  13. 7.3 AstraZeneca Plc
  14. 7.3.1 AstraZeneca Plc Company Information
  15. 7.3.2 AstraZeneca Plc Business Overview
  16. 7.3.3 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Plc Mitogen Activated Protein Kinase 14 Product Portfolio
  18. 7.3.5 AstraZeneca Plc Recent Developments
  19. 7.4 Zocere, Inc.
  20. 7.4.1 Zocere, Inc. Company Information
  21. 7.4.2 Zocere, Inc. Business Overview
  22. 7.4.3 Zocere, Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zocere, Inc. Mitogen Activated Protein Kinase 14 Product Portfolio
  24. 7.4.5 Zocere, Inc. Recent Developments
  25. 7.5 Toray Industries
  26. 7.5.1 Toray Industries Company Information
  27. 7.5.2 Toray Industries Business Overview
  28. 7.5.3 Toray Industries Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Toray Industries Mitogen Activated Protein Kinase 14 Product Portfolio
  30. 7.5.5 Toray Industries Recent Developments
  31. 7.6 Synovo GmbH
  32. 7.6.1 Synovo GmbH Company Information
  33. 7.6.2 Synovo GmbH Business Overview
  34. 7.6.3 Synovo GmbH Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Synovo GmbH Mitogen Activated Protein Kinase 14 Product Portfolio
  36. 7.6.5 Synovo GmbH Recent Developments
  37. 7.7 Chroma Therapeutics Limited
  38. 7.7.1 Chroma Therapeutics Limited Company Information
  39. 7.7.2 Chroma Therapeutics Limited Business Overview
  40. 7.7.3 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Chroma Therapeutics Limited Mitogen Activated Protein Kinase 14 Product Portfolio
  42. 7.7.5 Chroma Therapeutics Limited Recent Developments
  43. 7.8 Chiesi Farmaceutici SpA
  44. 7.8.1 Chiesi Farmaceutici SpA Company Information
  45. 7.8.2 Chiesi Farmaceutici SpA Business Overview
  46. 7.8.3 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Chiesi Farmaceutici SpA Mitogen Activated Protein Kinase 14 Product Portfolio
  48. 7.8.5 Chiesi Farmaceutici SpA Recent Developments
  49. 7.9 Astellas Pharma Inc.
  50. 7.9.1 Astellas Pharma Inc. Company Information
  51. 7.9.2 Astellas Pharma Inc. Business Overview
  52. 7.9.3 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Astellas Pharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolio
  54. 7.9.5 Astellas Pharma Inc. Recent Developments
  55. 7.10 Array BioPharma Inc.
  56. 7.10.1 Array BioPharma Inc. Company Information
  57. 7.10.2 Array BioPharma Inc. Business Overview
  58. 7.10.3 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Array BioPharma Inc. Mitogen Activated Protein Kinase 14 Product Portfolio
  60. 7.10.5 Array BioPharma Inc. Recent Developments
8 North America
  1. 8.1 North America Mitogen Activated Protein Kinase 14 Market Size by Type
  2. 8.1.1 North America Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032)
  3. 8.1.2 North America Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032)
  4. 8.1.3 North America Mitogen Activated Protein Kinase 14 Price by Type (2021-2032)
  5. 8.2 North America Mitogen Activated Protein Kinase 14 Market Size by Application
  6. 8.2.1 North America Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032)
  7. 8.2.2 North America Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032)
  8. 8.2.3 North America Mitogen Activated Protein Kinase 14 Price by Application (2021-2032)
  9. 8.3 North America Mitogen Activated Protein Kinase 14 Market Size by Country
  10. 8.3.1 North America Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mitogen Activated Protein Kinase 14 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Mitogen Activated Protein Kinase 14 Market Size by Type
  2. 9.1.1 Europe Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032)
  4. 9.1.3 Europe Mitogen Activated Protein Kinase 14 Price by Type (2021-2032)
  5. 9.2 Europe Mitogen Activated Protein Kinase 14 Market Size by Application
  6. 9.2.1 Europe Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032)
  8. 9.2.3 Europe Mitogen Activated Protein Kinase 14 Price by Application (2021-2032)
  9. 9.3 Europe Mitogen Activated Protein Kinase 14 Market Size by Country
  10. 9.3.1 Europe Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mitogen Activated Protein Kinase 14 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Mitogen Activated Protein Kinase 14 Market Size by Type
  2. 10.1.1 China Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032)
  3. 10.1.2 China Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032)
  4. 10.1.3 China Mitogen Activated Protein Kinase 14 Price by Type (2021-2032)
  5. 10.2 China Mitogen Activated Protein Kinase 14 Market Size by Application
  6. 10.2.1 China Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032)
  7. 10.2.2 China Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032)
  8. 10.2.3 China Mitogen Activated Protein Kinase 14 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mitogen Activated Protein Kinase 14 Market Size by Type
  2. 11.1.1 Asia Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032)
  4. 11.1.3 Asia Mitogen Activated Protein Kinase 14 Price by Type (2021-2032)
  5. 11.2 Asia Mitogen Activated Protein Kinase 14 Market Size by Application
  6. 11.2.1 Asia Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032)
  8. 11.2.3 Asia Mitogen Activated Protein Kinase 14 Price by Application (2021-2032)
  9. 11.3 Asia Mitogen Activated Protein Kinase 14 Market Size by Country
  10. 11.3.1 Asia Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mitogen Activated Protein Kinase 14 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mitogen Activated Protein Kinase 14 Market Size by Type
  2. 12.1.1 SAMEA Mitogen Activated Protein Kinase 14 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mitogen Activated Protein Kinase 14 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mitogen Activated Protein Kinase 14 Price by Type (2021-2032)
  5. 12.2 SAMEA Mitogen Activated Protein Kinase 14 Market Size by Application
  6. 12.2.1 SAMEA Mitogen Activated Protein Kinase 14 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mitogen Activated Protein Kinase 14 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mitogen Activated Protein Kinase 14 Price by Application (2021-2032)
  9. 12.3 SAMEA Mitogen Activated Protein Kinase 14 Market Size by Country
  10. 12.3.1 SAMEA Mitogen Activated Protein Kinase 14 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mitogen Activated Protein Kinase 14 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mitogen Activated Protein Kinase 14 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mitogen Activated Protein Kinase 14 Value Chain Analysis
  2. 13.1.1 Mitogen Activated Protein Kinase 14 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mitogen Activated Protein Kinase 14 Production Mode & Process
  6. 13.2 Mitogen Activated Protein Kinase 14 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mitogen Activated Protein Kinase 14 Distributors
  9. 13.2.3 Mitogen Activated Protein Kinase 14 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst